Skip to main content
main-content

Endocrinology

Paediatric endocrinology

Interested in paediatric endocrinology?

Visit our dedicated microsite for research news, interviews and in-depth analysis of paediatric endocrinology and growth disorders.

  • Novel ‘BDV syndrome’ has considerable clinical overlap with PWS

  • Harmonised BMD surveillance guidance for young cancer survivors released

  • Genetic testing can contribute to clinical diagnosis of delayed puberty

A resource for healthcare professionals caring for patients with Cushing’s syndrome

Cushing’s Hub logo

Selective glucocorticoid receptor modulation shows promise for Cushing’s syndrome

The selective glucocorticoid receptor modulator relacorilant may warrant further investigation for the treatment of endogenous Cushing’s syndrome, suggest phase 2 trial results published in Frontiers in Endocrinology in July 2021.

Long-term improvement of bone mineral density after Cushing’s syndrome treatment

Bone mineral density continues to improve for up to 20 years after treatment for Cushing’s syndrome, report Annenienke van de Ven and team.

Image Credits